Entero Therapeutics
ENTO
Reported
Monday, October 21
Q2 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.32 | -3.86 | -3.54 | -1106.25% |
| Revenue | - | 0.00 | - | - |
WhatIF - Earnings
EPS Missed Expectations by -$3.54
Entero Therapeutics (ENTO:NASDAQ) has never missed EPS by this much before
There’s a first time for everything